Login / Signup

The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy.

Aleksandra Karabinowska-MałochaEwa DziewięckaPaweł BanyśMałgorzata Urbańczyk-ZawadzkaMaciej KrupińskiMałgorzata MielnikJacek ŁachAleksandra BudkiewiczPiotr PodolecŁukasz ŻydzikSylwia Wiśniowska-ŚmiałekKatarzyna HolcmanMagdalena KostkiewiczPawel P Rubis
Published in: Journal of personalized medicine (2022)
Non-sustained ventricular tachycardia (nsVT) creates the electrical basis for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). We aimed to evaluate the relationship between interstitial fibrosis on cardiac magnetic resonance (CMR) and nsVT in HCM. A total of 50 HCM patients underwent CMR with a 3 T scanner to determine the presence of replacement fibrosis expressed by late gadolinium enhancement (LGE), and interstitial fibrosis expressed by native T₁, post-contrast T₁, and extracellular volume (ECV). The incidence of nsVT was assessed by Holter monitoring. We detected nsVT in 14 (28%) out of 50 HCM patients. Replacement fibrosis expressed by LGE was present in 37 (74%) patients and only showed a trend towards a differentiation between the groups with and without nsVT ( p = 0.07). However, the extent of LGE was clearly higher in the nsVT group (3.8 ± 4.9% vs. 7.94 ± 4.5%, p = 0.002) and was an independent predictor of nsVT in a multivariable regression analysis (OR 1.2; 95%CI 1.02-1.4; p = 0.02). No relationship was observed between interstitial fibrosis and nsVT. To conclude, it was found that it is not the mere presence but the actual extent of LGE that determines the occurrence of nsVT in HCM patients; the role of interstitial fibrosis remains unclear.
Keyphrases
  • hypertrophic cardiomyopathy
  • magnetic resonance
  • end stage renal disease
  • left ventricular
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • heart failure
  • patient reported outcomes